ETFs positioned on Amgen Inc.

Name YTD change Weight AuM
+15.71%-.--% 35,761 M€
+11.41%-.--% 27,154 M€
+7.19%-.--% 49 M€
+9.30%-.--% 66 M€
+9.48%-.--% 67 M€
+10.93%-.--% 67 M€
+6.77%-.--% 75 M€
+11.95%-.--% 122 M€
+3.78%-.--% 165 M€
+0.42%-.--% 33 M€
+14.96%-.--% 669 M€
+10.97%-.--% 1,251 M€
+24.53%-.--% 1,646 M€
+13.07%-.--% 1,674 M€
+18.99%-.--% 2,210 M€
+14.94%-.--% 2,303 M€
+10.81%-.--% 12,921 M€
+28.80%17.04% 429 M€
+22.60%8.97% 1,079 M€
+22.50%8.97% 78 M€
+23.99%8.81% 9,953 M€
+23.15%7.76% 81 M€
+11.29%7.16% 503 M€
+1.83%6.85% 5 M€
+18.36%5.86% 379 M€
+4.69%5.41% 7 M€
0.00%4.96% 5 M€
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500